v3.26.1
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Millions
Jun. 30, 2026
Dec. 31, 2025
Assets    
Cash and cash equivalents $ 231 $ 689
Restricted cash and cash equivalents (Note 16) 7 63
Accounts receivable (Note 3) 294 196
Inventory, net (Note 5) 298 278
Derivative instruments (Notes 2 and 11) 131 56
Other current assets 67 67
Total current assets 1,028 1,349
Property, plant and equipment, net (Note 7) 11,928 7,546
Nuclear decommissioning trust funds (Notes 6 and 11) 1,997 1,900
Derivative instruments (Notes 2 and 11) 9 4
Other noncurrent assets 106 106
Total Assets 15,068 10,905
Liabilities and Equity    
Long-term debt, due within one year (Notes 10 and 11) 29 29
Accrued interest 167 60
Accounts payable and other accrued liabilities 347 281
Derivative instruments (Notes 2 and 11) 573 101
Stock-based compensation liabilities (Note 13) 6 501
Other current liabilities 194 78
Total current liabilities 1,316 1,050
Long-term debt (Notes 10 and 11) 9,543 6,782
Derivative instruments (Notes 2 and 11) 150 67
Postretirement benefit obligations (Note 12) 214 229
Asset retirement obligations and accrued environmental costs (Note 8) 497 494
Deferred income taxes 904 486
Acquired contract liabilities (Note 17) 769 662
Other noncurrent liabilities 36 42
Total Liabilities 13,429 9,812
Commitments and Contingencies (Note 9)
Stockholders' Equity (Note 15)    
Common stock ($0.001 par value, 350,000,000 shares authorized) [1] 0 0
Additional paid-in capital 2,533 1,709
Accumulated retained earnings (deficit) (905) (612)
Accumulated other comprehensive income (loss) (12) (4)
Total Stockholders' Equity 1,616 1,093
Noncontrolling interests 23 0
Total Equity 1,639 1,093
Total Liabilities and Stockholders' Equity $ 15,068 $ 10,905
[1]
(a)47,900,355 and 45,687,828 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively.